HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endothelial cell-derived high molecular weight von Willebrand factor is converted into the plasma multimer pattern by granulocyte proteases.

Abstract
We have previously found that the von Willebrand factor released by cultured human umbilical vein endothelial cells appeared as a single high molecular weight band in glyoxyl agarose electrophoresis. In the present studies we report that this high molecular weight endothelial cell-derived von Willebrand factor, when incubated with granulocyte lysates, was cleaved into a series of multimers indistinguishable from those seen in normal plasma (or type II von Willebrand disease). This von Willebrand factor-cleaving activity was released from granulocytes by calcium ionophore A23187 but was not detected in cytosolic fractions depleted of granular contents. It was inhibited by the serine protease inhibitor phenylmethylsulfonyl fluoride. This von Willebrand factor-cleaving activity thus provides a possible mechanism for the generation of plasma von Willebrand factor multimers from the high molecular weight form of von Willebrand factor secreted by endothelial cells.
AuthorsH M Tsai, R L Nagel, V B Hatcher, I I Sussman
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 158 Issue 3 Pg. 980-5 (Feb 15 1989) ISSN: 0006-291X [Print] United States
PMID2493251 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Macromolecular Substances
  • Protease Inhibitors
  • von Willebrand Factor
  • Isoflurophate
  • Calcimycin
  • Phenylmethylsulfonyl Fluoride
  • Peptide Hydrolases
Topics
  • Calcimycin (pharmacology)
  • Cells, Cultured
  • Endothelium, Vascular (metabolism)
  • Granulocytes (drug effects, enzymology)
  • Humans
  • Isoflurophate (pharmacology)
  • Macromolecular Substances
  • Molecular Weight
  • Peptide Hydrolases (metabolism)
  • Phenylmethylsulfonyl Fluoride (pharmacology)
  • Protease Inhibitors (pharmacology)
  • Umbilical Veins
  • von Willebrand Factor (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: